C4 Therapeutics (CCCC) Share-based Compensation Growth (1y) (2020 - 2026)
C4 Therapeutics (CCCC) Share-based Compensation Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-69.95% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
C4 Therapeutics |
520.69 Mn |
285.02 Mn |
- |
-51.50% |
| Date | Value |
|---|
| Mar 31, 2026 |
-51.50% |
| Dec 31, 2025 |
-51.34% |
| Sep 30, 2025 |
-47.99% |
| Jun 30, 2025 |
-21.77% |
| Mar 31, 2025 |
-11.39% |
| Dec 31, 2024 |
29.50% |
| Sep 30, 2024 |
7.70% |
| Jun 30, 2024 |
-0.68% |
| Mar 31, 2024 |
-0.58% |
| Dec 31, 2023 |
-8.09% |
| Sep 30, 2023 |
36.42% |
| Jun 30, 2023 |
-21.15% |
| Mar 31, 2023 |
-30.06% |
| Dec 31, 2022 |
8.91% |
| Sep 30, 2022 |
-1.23% |
| Jun 30, 2022 |
55.85% |
| Mar 31, 2022 |
132.46% |
| Dec 31, 2021 |
133.65% |
| Sep 30, 2021 |
1,295.87% |
| Jun 30, 2021 |
3,147.20% |
